Funding for this research was provided by:
Ministry of Science and Technology of China (2017YFC1311100)
Beijing Municipal Science and Technology Commission (Z161100000516001, Z161100002616021)
Received: 1 June 2019
Accepted: 26 August 2019
First Online: 25 October 2019
Ethics approval and consent to participate
: The institutional review board of Peking University Institute of Mental Health (Sixth Hospital) approved the study. Written informed consent was obtained from each participant. The patient and his/her legal guardian both provided written consent for the patient to participate in the study.
: Not applicable.
: Sungmin Kang is the founder of PeopleBio, Inc. All other authors declare that they have no competing interests.